Dose Escalation

Related by string. dose escalation * DO Se : mg kg dose / escalations : label dose escalation * dose escalation study . dose escalation trial . dose escalation clinical . controlled dose escalation . dose dose escalation . dose escalation Phase . Phase 1b dose escalation . sequential dose escalation . Dose Escalation Study . multicenter dose escalation . dose escalation phase *

Related by context. Frequent words. (Click for all words.) 78 Improves Survival 77 Patient Enrollment 76 Single Dose 76 Pivotal Phase 76 Clinical Trial Results 76 Metastatic Melanoma 75 Drug Candidate 75 Renal Cell Carcinoma 75 II Clinical Trial 75 Chronic Hepatitis C 75 Phase III Clinical Trial 75 Prostate Cancer Patients 75 Phase III Trial 75 Well Tolerated 75 Monotherapy 74 Initiate Phase 74 Elderly Patients 73 Preclinical Data 73 Advanced Prostate Cancer 73 Receives Orphan Drug Designation 72 Pulmonary Arterial Hypertension 72 Pivotal Phase III 72 Gastric Cancer 72 Patients Undergoing 72 Pivotal Trial 72 Low Dose 72 FDA Accepts 72 Metastatic Colorectal Cancer 72 Completes Enrollment 71 Tolerability 71 Heart Failure Patients 71 Venous Thromboembolism 71 Presents Positive 71 Lung Cancer Patients 71 Pivotal Study 71 Gene Mutation 71 Postmenopausal Women 71 Generic Version 71 Cholesterol Drug 71 Benign Prostatic Hyperplasia 71 Initiates Phase II 70 Patients Treated 70 Immunogenicity 70 Solid Tumors 70 Combination Therapy 70 Significantly Improves 70 Drug Resistant 70 FDA Clears 70 Golimumab 70 Newly Diagnosed 70 Aliskiren 70 Bevacizumab 70 Pediatric Patients 70 Reduces Risk 70 Smallpox Vaccine 69 Cervical Cancer Vaccine 69 Tumor Growth 69 Targeted Therapy 69 Hormone Therapy 69 Commences Phase 69 Breast Cancer Treatment 69 Blood Thinner 69 Meta Analysis 69 Epratuzumab 69 Inhibits 69 Malaria Vaccine 69 Diabetic Patients 69 Cancer Vaccines 68 Stomach Cancer 68 RNAi Therapeutics 68 Initiates Phase 68 Increases Risk 68 Chronic Hepatitis B 68 Prostate Cancer Treatment 68 Cyclophosphamide 68 Tesetaxel 68 Develop Novel 68 Clinical Trials Update 68 Overactive Bladder 68 Study Demonstrates 68 Bortezomib 68 Denufosol 67 Autoimmune Disease 67 Monoclonal Antibody 67 Urinary Incontinence 67 Patient Outcomes 67 Bavituximab 67 SABCS 67 Cancer Treatments 67 Ofatumumab 67 Significantly Reduces 67 Insulin Resistance 67 Chronic Lymphocytic Leukemia 67 Lenalidomide 67 J Am Coll 67 Bladder Cancer 67 Natalizumab 67 Boceprevir 66 Small Molecule 66 Recombinant Human 66 Capecitabine

Back to home page